Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Olaparib +/− Atezolizumab for Advanced Breast Cancer
Recruiting1 awardPhase 2
Aurora, Colorado
This trial is testing olaparib with or without atezolizumab to treat non-HER2-positive breast cancer that has spread and is not able to be surgically removed or has metastasized.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.